BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19766472)

  • 1. Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress.
    Cavazzana-Calvo M; André-Schmutz I; Dal Cortivo L; Neven B; Hacein-Bey-Abina S; Fischer A
    Curr Opin Immunol; 2009 Oct; 21(5):544-8. PubMed ID: 19766472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
    Toubert A; Glauzy S; Douay C; Clave E
    Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
    Ball LM; Lankester AC; Bredius RG; Fibbe WE; van Tol MJ; Egeler RM
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S35-8. PubMed ID: 15812528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.
    Oevermann L; Lang P; Feuchtinger T; Schumm M; Teltschik HM; Schlegel P; Handgretinger R
    Ann N Y Acad Sci; 2012 Aug; 1266():161-70. PubMed ID: 22901267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
    Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
    Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Hentschke P; Omazic B; Mattsson J; Näsman-Björk I; Lundkvist I; Gigliotti D; Barkholt L; Ringdén O; Remberger M
    Scand J Immunol; 2005 Mar; 61(3):285-94. PubMed ID: 15787747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history and future prospective of haplo-identical stem cell transplantation.
    Handgretinger R; Lang P
    Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
    André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
    Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymus in GVHD pathophysiology.
    Krenger W; Holländer GA
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):119-28. PubMed ID: 18503980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
    Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
    Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.